Development of an HbA1c-based conversion equation for estimating glycated albumin in a Korean population with a wide range of glucose intolerance

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Jung, Chang Hee ^a   Hwang, You Cheol ^b   Kim, Kwang Joon ^c   Cha, Bong Soo ^c   Park, Cheol Young ^d   Jeon, Won Seon ^d   Kim, Jae Hyeon ^d   Jin, Sang Man ^d   Rhee, Sang Youl ^b   Woo, Jeong Taek ^b   Lee, Byung Wan ^c  

^a University of Ulsan College of Medicine   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; GLYCOSYLATED SERUM ALBUMIN; SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CALCULATION; CONVERSION EQUATION; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; GLYCEMIC INDEX; HEMOGLOBIN BLOOD LEVEL; HUMAN; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PROCESS DEVELOPMENT; REFERENCE VALUE; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CLINICAL TRIAL; HEALTH SURVEY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; RISK FACTOR; SOUTH KOREA;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PUBLIC HEALTH SURVEILLANCE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN;

EID: 84899753368     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095729     Document Type: Article

References (22)

1. International Expert C (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32: 1327-1334.
2. Kim KJ, Lee BW (2012) The roles of glycated albumin as intermediate glycation index and pathogenic protein. Diabetes Metab J 36: 98-107.
3. Kim D, Kim KJ, Huh JH, Lee BW, Kang ES, et al. (2012) The ratio of glycated albumin to glycated haemoglobin correlates with insulin secretory function. Clin Endocrinol (Oxf) 77: 679-683.
4. Lee EY, Lee BW, Kim D, Lee YH, Kim KJ, et al. (2011) Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients. Acta Diabetol 48: 167-172.
5. Song SO, Kim KJ, Lee BW, Kang ES, Cha BS, et al. (2012) Serum glycated albumin predicts the progression of carotid arterial atherosclerosis. Atherosclerosis 225: 450-455.
6. Koga M, Kasayama S (2010) Clinical impact of glycated albumin as another glycemic control marker. Endocr J 57: 751-762.
7. Tahara Y (2009) Analysis of the method for conversion between levels of HbA1c and glycated albumin by linear regression analysis using a measurement error model. Diabetes Res Clin Pract 84: 224-229.
8. American Diabetes A (2013) Standards of medical care in diabetes-2013. Diabetes Care 36 Suppl 1: S11-66.
9. Ko SH, Kim SR, Kim DJ, Oh SJ, Lee HJ, et al. (2011) 2011 clinical practice guidelines for type 2 diabetes in Korea. Diabetes Metab J 35: 431-436.
10. Muggeo VM (2003) Estimating regression models with unknown break-points. Stat Med 22: 3055-3071.
11. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.
12. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853.
13. Rhee SY, Chon S, Kwon MK, Park Ie B, Ahn KJ, et al. (2011) Prevalence of chronic complications in korean patients with type 2 diabetes mellitus based on the korean national diabetes program. Diabetes Metab J 35: 504-512.
14. Al-Ansary L, Farmer A, Hirst J, Roberts N, Glasziou P, et al. (2011) Point-ofcare testing for Hb A1c in the management of diabetes: a systematic review and metaanalysis. Clin Chem 57: 568-576.
15. Pu LJ, Lu L, Xu XW, Zhang RY, Zhang Q, et al. (2006) Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol 5: 27.
16. Kohzuma T, Yamamoto T, Uematsu Y, Shihabi ZK, Freedman BI (2011) Basic performance of an enzymatic method for glycated albumin and reference range determination. J Diabetes Sci Technol 5: 1455-1462.
17. Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, et al. (2007) Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem 40: 1398-1405. (Pubitemid 350151420)
18. Makoto T, Hideichi M, Gen Y, Katsuhiko K, Izumi T, et al. (2006) Report of the Committee on Standardization of Laboratory Testing Related to Diabetes Mellitus of the Japan Diabetes Society: determination of reference intervals of hemoglobin A1c (IFCC) and glycoalbumin in the Japanese population. J Japan Diab Soc 49: 825-833.
19. Zhou J, Li H, Yang WY, Ran XW, Li Q, et al. (2009) A multi-center clinical study of the reference value of serum glycated albumin. Zhonghua Nei Ke Za Zhi 48: 469-472.
20. Garlick RL, Mazer JS (1983) The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J Biol Chem 258: 6142-6146. (Pubitemid 13106789)
21. Iberg N, Fluckiger R (1986) Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. J Biol Chem 261: 13542-13545. (Pubitemid 17196372)
22. Rondeau P, Bourdon E (2011) The glycation of albumin: structural and functional impacts. Biochimie 93: 645-658.